Jubilant Ingrevia Q1 Profit Rises 22.46% to ₹105.82 Crore
Jubilant Ingrevia reports strong Q1 results, revenue up 25.33%

Jubilant Ingrevia Limited has announced its consolidated financial results for the first quarter of fiscal year 2027, reporting a net profit after tax of ₹105.82 crore for the quarter ended 30 June 2026. This marks a 22.46% increase compared to ₹86.44 crore in the preceding quarter and a 40.91% increase from ₹75.10 crore in the year-ago quarter.
The company's consolidated revenue from operations stood at ₹1,300.27 crore for Q1 FY27, representing a 10.32% increase from ₹1,178.65 crore in Q4 FY26 and a 25.33% increase from ₹1,037.87 crore in Q1 FY26. Total income for the quarter reached ₹1,310.49 crore.
Total expenses for the quarter ended 30 June 2026 were ₹1,169.60 crore. Consolidated profit before tax for Q1 FY27 was ₹140.86 crore, compared to ₹111.71 crore in Q4 FY26 and ₹99.77 crore in Q1 FY26.
Basic earnings per share for the quarter was ₹6.70, an increase from ₹5.47 in the preceding quarter and ₹4.75 in the year-ago quarter. The company reported exceptional items of ₹13.04 crore as an expense for the year ended 31 March 2026, relating to a one-time impact of new labour codes.
The Speciality Chemicals segment revenue was ₹637.00 crore, while Nutrition & Health Solutions contributed ₹243.82 crore. Chemical Intermediates reported revenue of ₹525.17 crore for the quarter.
Jubilant Ingrevia's statement included results from several subsidiaries, including Jubilant Infrastructure Limited, Jubilant Agro Science Limited, and Jubilant Ingrevia (USA) Inc. Associates included Mister Veg Foods Private Limited and AMP Energy Green Fifteen Private Limited.
The strong Q1 results are a positive sign for the company, indicating a significant increase in revenue and profit. The growth in revenue is attributed to the increase in demand for specialty chemicals and nutrition and health solutions.
The company's financial performance is expected to continue to grow, driven by the increasing demand for its products. The strong Q1 results have set a positive tone for the rest of the fiscal year.
In terms of significance, the strong Q1 results of Jubilant Ingrevia are a positive sign for the Indian chemical industry, indicating a growth in demand for specialty chemicals and nutrition and health solutions. The company's performance is expected to have a positive impact on the industry as a whole, driving growth and investment in the sector.
Overall, the strong Q1 results of Jubilant Ingrevia are a significant development for the company and the Indian chemical industry, indicating a positive trend and growth prospects for the future.
The company's financial performance is a reflection of its strong business strategy and execution, and the Q1 results are a testament to its ability to deliver growth and profitability. The strong results are expected to boost investor confidence and drive growth in the company's stock price.
In conclusion, the strong Q1 results of Jubilant Ingrevia are a significant development for the company and the Indian chemical industry, indicating a positive trend and growth prospects for the future. The company's financial performance is expected to continue to grow, driven by the increasing demand for its products, and the strong Q1 results have set a positive tone for the rest of the fiscal year.
Frequently asked questions
What is Jubilant Ingrevia's Q1 FY27 net profit?
Jubilant Ingrevia's Q1 FY27 net profit is ₹105.82 crore.
What is the company's consolidated revenue from operations for Q1 FY27?
The company's consolidated revenue from operations for Q1 FY27 is ₹1,300.27 crore.